Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avalon PolyTom is a specialized subsidiary of Avalon GloboCare focused on advancing structural biology and drug discovery through its proprietary PolyTom technology. The company utilizes a unique flash-freeze method for high-throughput protein crystallization, which is designed to determine the three-dimensional structures of complex biological molecules. This platform is particularly effective for challenging targets such as G-protein coupled receptors (GPCRs), which are critical in many disease pathways. By providing high-resolution structural data, Avalon PolyTom facilitates the rational design of small molecules and biologics. The entity operates as a key research and development arm within the broader Avalon GloboCare portfolio, supporting its mission to develop innovative healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avalon PolyTom.